Articolo

When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies

  • Erika Wissinger

  • David Ringger, PHD

  • Casper Paardekooper

  • Diane Smith

This article was originally published on ISPOR

Global drug pricing decisions do not happen in isolation

This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization. 

Click below to read the full article today.

Siamo qui per aiutarti

Contatta il nostro team oggi stesso per saperne di più su come Cencora sta contribuendo a plasmare il futuro dell'assistenza sanitaria.

Risorse correlate

Webinar

The first Joint Clinical Assessment is here: What market access teams should learn now

Guida

La guida essenziale alla commercializzazione dei farmaci

Webinar

Il potenziale trasformativo dell'IA nell'HEOR e nell'accesso al mercato